At its worst, the doctrine condescends to patients, justifying denying funded access to a treatment on the basis it would be inequitable and unfair to others. This is an utterly false construct that pits patient against patient.
The mindset is that equitable access can only be achieved by denying everyone on the same basis
February 5, 2025 Latest NewsBioPharmaCommentLatest Video
New Stories
-
Omico calls for major government-industry support of fundamental change in cancer treatment
February 5, 2025 - - Latest News -
The mindset is that equitable access can only be achieved by denying everyone on the same basis
February 5, 2025 - - Latest News -
Baxter Kidney Care is now Vantive, a standalone organ therapy company
February 5, 2025 - - Latest News -
How is it fair that patients have no rights in this system of health technology assessment?
February 4, 2025 - - Latest News -
Pharmac tables proposal to fund a new oral contraceptive
February 4, 2025 - - Latest News -
'For many people living with cancer, the journey is complex and fraught with difficulties'
February 4, 2025 - - Latest News -
Patients have, in the health minister's own words, died waiting for this process
February 3, 2025 - - Latest News